Company / CapEx per Share
Traws Pharma, Inc. CapEx per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.00
FY2024
5-year range
$0.00 / $0.00
FY2020-FY2024
Trend
+473.2%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
CapEx per Share changed +473% YoY in FY2024, a notable deviation from the 5-year average annual change of +97%.
Based on SEC 10-K filings.
0.00 in FY2024 with a 5-year CAGR of -16.9%.
Improved from $0.00 to $0.00 over the past 3 years.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- +43.7%
- 5-Year CAGR
- -16.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, capex per share increased 473.2% year-over-year.
- Peak capex per share was recorded in FY2015.
- Lowest capex per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -42.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.00 | +473.2% |
| FY2023 | $0.00 | - |
| FY2022 | - | - |
| FY2021 | $0.00 | +161.1% |
| FY2020 | $0.00 | -94.9% |
| FY2019 | $0.01 | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
| FY2015 | $0.01 | -19.2% |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026